A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life

✍ Scribed by S. B. Jensen; A. M. L. Pedersen; A. Vissink; E. Andersen; C. G. Brown; A. N. Davies; J. Dutilh; J. S. Fulton; L. Jankovic; N. N. F. Lopes; A. L. S. Mello; L. V. Muniz; C. A. Murdoch-Kinch; R. G. Nair; J. J. Napeñas; A. Nogueira-Rodrigues; D. Saunders; B. Stirling; I. von Bültzingslöwen; D. S. Weikel; L. S. Elting; F. K. L. Spijkervet; M. T. Brennan; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

• Publisher: Springer-Verlag
• Year: 2010
• Tongue: English
• Weight: 397 KB
• Volume: 18
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-010-0827-8